by Alison Bass | Nov 19, 2008 | Uncategorized
I found a disturbing common thread emerge this week from news coverage of the medical-pharmaceutical industry, a thread that can be summed in these words: If you can’t buy them, bully them. First off, we have reports in The New York Times and Pharmalot that an...
by Alison Bass | Nov 6, 2008 | Uncategorized
Between teaching journalism and working on my master’s thesis, I have only now found the time to scrutinize the much-heralded Zoloft study published last Friday in the online version of The New England Journal of Medicine. And I have a few bones to pick with it,...
by Alison Bass | Oct 28, 2008 | Uncategorized
In 2003. researchers at Tufts University published a study showing that it cost drug companies approximately $800 million to develop a new drug and get it approved by the FDA. In the intervening years, the drug industry has used that mind-boggling cost estimate to...
by Alison Bass | Oct 22, 2008 | Uncategorized
A bewildered tone seemed to permeate the news reports this week that suicide rates among middle-aged Americans rose sharply from 1999 to 2005. Even the authors of the new analysis in the American Journal of Preventive Medicine said they had no idea why the suicide...
by Alison Bass | Oct 15, 2008 | Uncategorized
The Senate Finance Committee’s probe of physicians with extensive financial conflicts is gathering steam: first, Stanford University removed its psychiatry chief Alan Schatzberg as principal investigator of a federally funded study after Congressional investigators...
